Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$247.84 - $340.0 $94,427 - $129,540
-381 Reduced 27.41%
1,009 $338,000
Q4 2023

Feb 09, 2024

SELL
$222.83 - $285.76 $228,846 - $293,475
-1,027 Reduced 42.49%
1,390 $393,000
Q3 2023

Nov 02, 2023

SELL
$236.44 - $265.62 $7,566 - $8,499
-32 Reduced 1.31%
2,417 $595,000
Q2 2023

Aug 08, 2023

BUY
$183.12 - $250.2 $170,484 - $232,936
931 Added 61.33%
2,449 $612,000
Q1 2023

May 01, 2023

SELL
$193.59 - $245.33 $126,220 - $159,955
-652 Reduced 30.05%
1,518 $324,000
Q4 2022

Feb 08, 2023

BUY
$173.9 - $224.8 $377,363 - $487,816
2,170 New
2,170 $0

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.6B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.